Clinical and Molecular Hepatology10.3350/cmh.2022.01862022283425-472Therapeutic mechanisms and beneficial effects of non-antidiabetic drugs in chronic liver diseasesHan Ah Lee, Young Chang, Pil Soo Sung, Eileen L. Yoon, Hye Won Lee, Jeong-Ju Yoo, Young-Sun Lee, Jihyun An, Do Seon Song, Young Youn Cho, Seung Up Kim, Yoon Jun Kim,,
Alimentary Pharmacology & Therapeutics10.1046/j.1365-2036.1999.00596.x1999138979-995Review article: mechanisms of action and therapeutic applications of ursodeoxycholic acid in chronic liver diseases Trauner, Graziadei,,
Journal of the Chinese Medical Association10.1016/j.jcma.2014.04.0102014777343-344Mechanisms of the beneficial effects of Ger-Gen-Chyn-Lian-Tang on acute and chronic liver injuryYing-Ying Yang,,
Phytotherapy Research10.1002/ptr.5667201630101559-1571Non-alcoholic Fatty Liver Disease: Beneficial Effects of FlavonoidsMasoumeh Akhlaghi,
Drugs10.1007/s40265-016-0546-72016765533-549Serious Non-AIDS Events: Therapeutic Targets of Immune Activation and Chronic Inflammation in HIV InfectionDenise C. Hsu, Irini Sereti,,,
Clinical Physiology and Functional Imaging10.1111/cpf.125262018392122-127Cardiometabolic effects of antidiabetic drugs in non‐alcoholic fatty liver diseaseIben Rix, Julie Steen Pedersen, Heidi Storgaard, Lise Lotte Gluud,
Journal of Applied Toxicology10.1002/jat.1310200828293-103Beneficial drugs for liver diseasesPablo Muriel, Yadira Rivera-Espinoza,
Mechanisms of Neuroinflammation10.5772/intechopen.689382017Neuroinflammatory Signals during Acute and Chronic Liver DiseasesMatthew McMillin, Sharon DeMorrow
Hepatobiliary & Pancreatic Diseases International10.1016/s1499-3872(15)60355-12015142139-144Beneficial mechanisms of aerobic exercise on hepatic lipid metabolism in non-alcoholic fatty liver diseaseRui Guo, Emily C Liong, Kwok Fai So, Man-Lung Fung, George L Tipoe,
Journal of Chronic Diseases10.1016/0021-9681(72)90187-719722510-11653Dependence Liability of ‘Non-Narcotic’ DrugsJoseph H. Skom,